Pedido rápido

PD-L1/B7-H1/CD274  Proteína

All CD274 Reagents

Anfitrión de expresión: Human Cells  
  • Slide 1
10084-H05H-20
10084-H05H-100
20 µg 
100 µg 
Add to Cart
Descripción del producto: Active  
Anfitrión de expresión: Human Cells  
  • Slide 1
10084-H02H-200
10084-H02H-100
200 µg 
100 µg 
Add to Cart
Descripción del producto: Active  
Anfitrión de expresión: Human Cells  
  • Slide 1
10084-H08H-200
10084-H08H-100
200 µg 
100 µg 
Add to Cart
Descripción del producto: Active  
Anfitrión de expresión: Human Cells  
  • Slide 1
50010-M03H-200
50010-M03H-100
200 µg 
100 µg 
Add to Cart
Descripción del producto: Active  
Anfitrión de expresión: Human Cells  
  • Slide 1
50010-M08H-200
50010-M08H-100
200 µg 
100 µg 
Add to Cart
Anfitrión de expresión: Human Cells  
  • Slide 1
50010-M02H-200
50010-M02H-100
200 µg 
100 µg 
Add to Cart
Anfitrión de expresión: Human Cells  
  • Slide 1
80450-R02H-200
80450-R02H-100
200 µg 
100 µg 
Add to Cart
Anfitrión de expresión: Human Cells  
  • Slide 1
80450-R08H-200
80450-R08H-100
200 µg 
100 µg 
Add to Cart
Anfitrión de expresión: Human Cells  
  • Slide 1
90251-C02H-200
90251-C02H-100
200 µg 
100 µg 
Add to Cart
Anfitrión de expresión: Human Cells  
  • Slide 1
90251-C08H-200
90251-C08H-100
200 µg 
100 µg 
Add to Cart
Anfitrión de expresión: Human Cells  
  • Slide 1
70110-D02H-200
70110-D02H-100
200 µg 
100 µg 
Add to Cart

Browse PD-L1/B7-H1/CD274 Products by

PD-L1/B7-H1/CD274 Related Area

PD-L1/B7-H1/CD274 Vías relacionadas

    PD-L1/B7-H1/CD274 Resumen e información sobre la proteína

    PD-L1/B7-H1/CD274 Fondo

    Estructura de subunidad: Interacts with PDCD1.
    Localización subcelular: Isoform 1: Cell membrane; Single-pass type I membrane protein.
    Isoform 2: Endomembrane system; Single-pass type I membrane protein.
    Especificidad del tejido: Highly expressed in the heart, skeletal muscle, placenta and lung. Weakly expressed in the thymus, spleen, kidney and liver. Expressed on activated T- and B-cells, dendritic cells, keratinocytes and monocytes.
    Inducción: Up-regulated on T- and B-cells, dendritic cells, keratinocytes and monocytes after LPS and IFNG activation. Up- regulated in B-cells activated by surface Ig cross-linking.
    Similitud de la secuencia: Belongs to the immunoglobulin superfamily. BTN/MOG family.
    Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
    Contains 1 Ig-like V-type (immunoglobulin-like) domain.
    General information above from UniProt

    Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 family expressed on activated lymphoid cells. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.

    Immune Checkpoint
    Immune Checkpoint Blockade: Blocking Antibodies   Immune Checkpoint Blockade: PD-L1 / B7-H1 / CD274 Blocking Antibodies
    Immune Checkpoint Detection: Antibodies   Immune Checkpoint Detection: ELISA Antibodies   Immune Checkpoint Detection: IHC Antibodies   Immune Checkpoint Detection: ICC Antibodies   Immune Checkpoint Detection: FCM Antibodies   Immune Checkpoint Detection: WB Antibodies
    Immune Checkpoint Proteins   PD-L1 / B7-H1 / CD274 Immune Checkpoint Proteins
    Immune Checkpoint Targets   Co-inhibitory Immune Checkpoint Targets

    Immunotherapy   Cancer Immunotherapy   Targeted Therapy

    PD-L1/B7-H1/CD274 Nombre alternativo

    PD-L1/B7-H1/CD274 Estudios relacionados

  • Iwai Y, et al. (2002) Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 99(19): 12293-7.
  • Ghebeh H, et al. (2006) The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. 8(3): 190-8.
  • Salih HR, et al. (2006) The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans. Exp Hematol. 34(7): 888-94.
  • Wilcox RA, et al. (2009) B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood. 114(10): 2149-58.
  • Ruggiero A, et al. (2009) Crystal structure of PD-L1, a ribosome inactivating protein from Phytolacca dioica L. leaves with the property to induce DNA cleavage. Biopolymers. 91(12): 1135-42.
  • Nota: Todos los productos son "PARA SU USO ÚNICAMENTE EN INVESTIGACIÓN Y NO INDICADOS PARA SU USO DIAGNÓSTICO O TERAPÉUTICO"